{"doi":"10.1038/npp.2017.209","title":"Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ9-Tetrahydrocannabinol","abstract":null,"journal":"Neuropsychopharmacology","year":2018,"id":17944,"datarank":8.549978283378563,"base_score":5.44673737166631,"endowment":5.44673737166631,"self_citation_contribution":0.8170106057499466,"citation_network_contribution":7.732967677628616,"self_endowment_contribution":0.8170106057499466,"citer_contribution":7.732967677628616,"corpus_percentile":null,"corpus_rank":null,"citation_count":231,"citer_count":200,"citers_with_citation_signal":185,"citers_with_endowment":185,"datacite_reuse_total":4,"is_dataset":false,"is_dataset_confidence":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":126542,"name":"Jacques D Nguyen","orcid":null,"position":1,"is_corresponding":false},{"id":126543,"name":"Daralyn Morgenson","orcid":null,"position":2,"is_corresponding":false},{"id":126544,"name":"Michael A Taffe","orcid":"0000-0001-9827-1738","position":3,"is_corresponding":false},{"id":126545,"name":"Mohini Ranganathan","orcid":null,"position":4,"is_corresponding":false},{"id":126541,"name":"Douglas L Boggs","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":5.44673737166631,"endowment":5.44673737166631,"datacite_reuse_total":4,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"28875990","pmcid":"PMC5719112","openalex_id":"https://openalex.org/W2750716611","authors":[],"funders":[{"funder_name":"NCATS NIH HHS","grant_id":"UL1 TR001863","title":null},{"funder_name":"National Institutes of Health","grant_id":"3R01DA035482-02S1","title":"Cannabinoid regulation of cognition"},{"funder_name":"National Institutes of Health","grant_id":"1R44DA041967-01","title":"Development of Rodent Self-Administration Vapor Inhalation Chambers for THC"}],"total_grants":3,"fwci":16.4706,"citation_percentile":0.99521858,"influential_citations":13,"citation_trend":[{"year":2017,"count":2},{"year":2018,"count":13},{"year":2019,"count":28},{"year":2020,"count":40},{"year":2021,"count":46},{"year":2022,"count":27},{"year":2023,"count":28},{"year":2024,"count":17},{"year":2025,"count":22},{"year":2026,"count":8}],"oa_status":"bronze","license":"Springer TDM","oa_locations":[{"url":"https://www.nature.com/articles/npp2017209.pdf","host_type":"journal"},{"url":"https://www.nature.com/articles/npp2017209.pdf","host_type":"BRONZE"},{"url":"https://www.nature.com/articles/npp2017209.pdf","host_type":"publisher"},{"url":"https://www.nature.com/articles/npp2017209","host_type":"publisher"},{"url":"http://www.nature.com/doifinder/10.1038/npp.2017.209","host_type":"publisher"},{"url":"https://doi.org/10.1038/npp.2017.209","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/28875990","host_type":"repository"},{"url":"https://escholarship.org/uc/item/69028372","host_type":"repository"},{"url":"http://europepmc.org/pmc/articles/PMC5719112","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5719112","host_type":"repository"},{"url":"https://dx.doi.org/10.1038/npp.2017.209","host_type":""},{"url":"https://escholarship.org/content/qt69028372/qt69028372.pdf","host_type":""},{"url":"https://doi.org/https://doi.org/10.1038/npp.2017.209","host_type":""}],"fields_of_study":["Cannabis and Cannabinoid Research","GABA and Rice Research","Sleep and Wakefulness Research","Medicine","Chemistry","0302 clinical medicine","03 medical and health sciences","Animals","Cannabidiol","Cannabinoid Receptor Agonists","Dronabinol","Drug Interactions","Humans"],"mesh_terms":["Animals","Cannabidiol","Drug Interactions","Humans","Dronabinol","Cannabinoid Receptor Agonists"],"keywords":["Cannabidiol","Cannabis","Tetrahydrocannabinol","Psychosis","Effects of cannabis","Cannabinoid","Anxiety","Dronabinol","Pharmacology","Psychology","Psychiatry","Delta-9-tetrahydrocannabinol","Schizophrenia (object-oriented programming)","Cognition","Medicine","Internal medicine","Therapeutic Cannabinoid Research","Cannabidiol Research (rcdc)","Biological Psychology","11 Medical and Health Sciences (for)","Medical and Health Sciences","Substance Misuse","Animals (mesh)","Drug Interactions","32 Biomedical and Clinical Sciences (for-2020)","Neurosciences (rcdc)","3214 Pharmacology and Pharmaceutical Sciences (for-2020)","Humans (mesh)","Substance Misuse (rcdc)","3 Good Health and Well Being (sdg)","Dronabinol (mesh)","52 Psychology (for-2020)","Drug Abuse (NIDA only) (rcdc)","Pharmacology and Pharmaceutical Sciences","Mental Illness","3209 Neurosciences (for-2020)","Mental Health","Cannabidiol (mesh)","5202 Biological Psychology (for-2020)","Behavioral and Social Science (rcdc)","Mental Health (rcdc)","Mental Illness (rcdc)","Cannabidiol Research","610","Therapeutic Cannabinoid Research (rcdc)","Psychiatry (science-metrix)","Cannabinoid Receptor Agonists (mesh)","Drug Interactions (mesh)","Complementary and Integrative Health","Behavioral and Social Science","Animals","Humans","17 Psychology and Cognitive Sciences (for)","Cannabinoid Receptor Agonists","Cannabinoid Research (rcdc)","Biomedical and Clinical Sciences","Cannabinoid Research","Psychology and Cognitive Sciences","Neurosciences","Mental health (hrcs-hc)","Complementary and Integrative Health (rcdc)","Good Health and Well Being","Drug Abuse (NIDA only)"],"sdg_mappings":[{"sdg_number":3,"sdg_label":"3. Good health"},{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[{"doi":"10.6084/m9.figshare.13710521.v1","title":"Additional file 1 of Cannabinoid treatment for autism: a proof-of-concept randomized trial","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.13710521","title":"Additional file 1 of Cannabinoid treatment for autism: a proof-of-concept randomized trial","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.13710524.v1","title":"Additional file 2 of Cannabinoid treatment for autism: a proof-of-concept randomized trial","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.13710524","title":"Additional file 2 of Cannabinoid treatment for autism: a proof-of-concept randomized trial","publisher":"figshare","resource_type":"JournalArticle"}],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-03T02:37:40.640680Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}